IXDEX. 775 



PAGE 



therapy, 500 ; transmission, 500 ; see Bacillus meli- 

 tensis. 



Measles 747-750 



Complications and sequela?. 74f) : contagiousness of, 

 748; immunity and susceptibility, 749; leprosy, in- 

 fluence on, 621 ; leucocytes in, 750 ; Micrococcus 

 catarrhalis in, 550 ; micro-organisms in, 747 ; pro- 

 phylaxis, 749 ; racial immunization, 749 ; resistance 

 of virus, 749 ; recurrences, 749 ; serotherapy, 750 ; 

 virus, distribution of, 748. 



Meat poisoning. 



Bacillus botulinus in, 419 : Bacillus enteritidis in, 

 459-463 ; Bacillus paratyphosus in, 450 ; relation of 

 ptomaines to, 460. 



Mediterranean fever ; see Malta fever. 



Meningitis. 



B. pnciitnonife in, 572; colon bacillus in, 467: in influ- 

 enza, 566 ; micro-organisms causing, 319, 556 ; 

 pneumococcus in, 509, 514 ; secondary, 522 ; strep- 

 tococcus in, 520, 522, 524 ; tuberculous, 587. 



Meningitis, epidemic cerebrospinal 556-563 



Agglutination test, 560 ; cerebrospinal character of, 

 559 ; complications, 559 ; contagiousness of, 559 ; 

 immunity, acquired, 560 ; lumbar puncture for diag- 

 nosis. 559 ; metastatic infections. 559 ; mixed and 

 secondary infections in, 559 ; prophylaxis of, 560 ; 

 secondary to rhinitis, 558 ; serum properties of, 

 560 ; susceptibility to. 560 ; transmission of, 559 ; 

 see Micrococcus meningitidis. 



Meningococcus ; see Micrococcus meningitidis. 



Metchnikoff's theory ; see Phagocytosis. 



Methylene blue, effect of, on malarial parasites 661 



Microbic specificity 4 



Micrococcus catarrhalis 550, 551 



Animals, susceptibility of, to, 551 ; bronchitis, in, 551. 

 559 ; measles in, 550 ; occurrence in respiratory 

 passages, 550 ; occurrence under normal conditions, 

 551 ; pneumonia, in. 502, 510, 551, 560 ; resemblance 

 to meningococcus, 560 ; scarlet fever in, 550 ; 

 whooping-cough, in, 550. 



Micrococcus gonorrhea; (gonococcus) 383 



Antiserum for, 555 ; cultivation of, 551 ; discovery of, 

 551 ; endotoxin of. 552 ; gonotoxin, 553 ; immuniza- 

 tion with. 555 ; infections with. 551, 555 ; mor- 

 hology, 551 ; phagocytosis of 552 ; resistance of, 

 52 ; toxin, soluble, 555 ; see Gonorrhea. 



Micrococcus hematodes 541 



Micrococcus m elite nsis ; see Bacillus melitensis. 



Micrococcus meningitidis (Diplococcus intracellularis 

 meningitidis, or the meningococcus) 25, 556-563 



Agglutination of, 560 ; animals, susceptibility of, 557 ; 

 antiserum, properties of. 561 ; bronchitis, in, 559 ; 

 conjunctivitis in, 559 ; cultivation, 557 ; 'discovery, 

 556 ; endotoxin, 558 ; excretion of, 559 ; immuniza- 

 tion with, 560 ; morphology. 557 ; pneumonia, in, 

 559 ; resemblance to gonococcus, 557 ; resemblance 

 to Micrococcus catarrhalis. 559 ; resistance. 557 ; 

 rhinitis in, 559 ; virulence. 558 ; see Meningitis, 

 epidemic cerebrospinal. 



Microcytase 308-319 



Micro-organisms. 



Acquired resistance of. 116 : early belief in. 2 ; excre- 

 tion of, 37; recognition of, 3 -/sources of, in earth, 



